BIND Therapeutics' Grant

BIND Therapeutics raised a round of funding on October 09, 2007. Investors include National Cancer Institute.

BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its medicinal nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal nano…

Articles about BIND Therapeutics' Grant: